What Latch sells
In its own words, read on its own site 15 Oct 2026. On the vendor register
- What it sells
Evaluations and benchmarks: “Benchmarks and evaluations of AI models across the biosecurity-relevant capabilities that matter, from advancing biological threats to strengthening biodefense.” latch.bio
Datasets: “A 30M cell observational atlas spanning 150 diseases, 200 tissues and 27 technologies” blog.latch.bio
Annotation: “helps them perform tasks like count matrix construction, cell typing and metadata harmonization with greater efficiency and accuracy” blog.latch.bio
- Where its data comes from
Public data: “The data used for these evaluations is from publicly available manuscripts, case studies, or databases.” latch.bio
Made by experts and contractors: “Our first 30M cell atlas represents thousands of hours of human labor - the combined efforts of the Pythia Biosciences, Miraomics and LatchBio curation teams.” blog.latch.bio
- Buys data from owners
- Its pages do not say it does.
- Areas its pages name
- Science, Medical, Security
Cite this
AIData.Broker, “Latch in the AI training data market”, reviewed 15 Oct 2026. https://aidata.markets/companies/latch
Free to reuse under CC BY 4.0 if you credit AIData.Broker and link to this page. Each row names the publication that stated it, and words quoted from a source keep that source's own terms.